VC firm

RA Capital

15 investors · 15 verified

Here are all investors at RA Capital.

Investor preview

emails unlock with a plan

Investors on this list. Email addresses unlock with a plan.
namefirmemaillocationverified
Rajeev ShahManaging DirectorRA CapitalUnited States1w ago
Jenna HebertAssociateRA CapitalUnited States3w ago
Zach ScheinerPrincipalRA CapitalUnited States3w ago
Emily MinkowVenture PartnerRA CapitalUnited States3w ago
Jack VailasSenior AssociateRA CapitalUnited States3w ago
Daniel BahcheliAssociateRA CapitalUnited States3w ago
Reza HalsePartnerRA CapitalUnited States3w ago
Anthony ArceciAssociateRA CapitalUnited States3w ago
Peter KolchinskyManaging PartnerRA CapitalUnited States4w ago
Laura StoppelPrincipalRA CapitalUnited States4w ago
Andrew LevinManaging PartnerRA Capital4w ago
Cristina GhenoiuPrincipalRA CapitalUnited States4w ago
Anurag KondapalliPrincipalRA CapitalUnited States4w ago
Jake SimsonPartnerRA CapitalUnited States4w ago
Derek DiRoccoPartnerRA CapitalUnited States4w ago

Browse all VCs

Recent investments at RA Capital

  • CellCentricSeries D · $220M · 2026
  • Stipple BioSeries A · $100M · 2026
  • Slate MedicinesSeries A · $130M · 2026
  • Juvena TherapeuticsSeries B · $34M · 2026
  • Parabilis MedicinesSeries F · $310M · 2026
  • Imbria PharmaceuticalsSeries B · $67M · 2025
  • Artios PharmaSeries D · $120M · 2025
  • Bambusa TherapeuticsSeries A · $90M · 2025
  • Sparrow PharmaceuticalsSeries B · $95M · 2025
  • Alchemab TherapeuticsSeries A · $32M · 2025
  • GametoSeries C · $44M · 2025
  • Pahr TherapeuticsSeed · $14M · 2025

What founders say

4.1Based on 11 reviews